Fortune Rankings
America's Most Innovative Companies
World's Most Admired Companies
Global 500
Fortune 500
- Updated:1/31/24
- Country:U.S.
- Headquarters:New Brunswick, N.J.
- Industry:Pharmaceuticals
- CEO:Joaquin Duato
- Website:https://www.jnj.com
- Ticker:JNJ
- Company type:Public
- Revenues ($M):$95,195
- Profits ($M):$35,153
- Market value ($M):$377,758
- Number of employees:131,900
Figures are for fiscal year ended Dec. 31, 2023. Market value as of March 18, 2024. Sources: SEC filings; S&P Global.
- $ Millions% change
- Revenues ($M):$94,9431.2%
- Profits ($M):$17,941-14.1%
- Assets ($M):$187,378-
- Total Stockholder Equity ($M):$76,804-
- Profit as % of Revenues:18.9%
- Profits as % of Assets:9.6%
- Profits as % of Stockholder Equity:23.4%
- Earnings Per Share ($):6.73
- EPS % Change (from 2021):-13.8%
- EPS % Change (5 year annual rate):70.3%
- EPS % Change (10 year annual rate):5.7%
- Total Return to Investors (2022):6%
- Total Return to Investors (5 year, annualized):7.6%
- Total Return to Investors (10 year, annualized):12.7%
- Impact Segment:Public Health/Nutrition
- Sector:Health Care
- Industry:Pharmaceuticals
- CEO:Alex Gorsky
- Website:https://www.jnj.com
- Employees:134,000
- Company Type:Public
- Revenues ($M) (Last Fiscal Year):$76,450
- Profits ($M) (Last Fiscal Year):$1,300
- Market Value ($M) as of 8/12/19:$350,314
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:27
- Previous All-Star Rank:22
- Industry Rank:2
- Previous Industry Rank:1
- Overall Score:7.66
- Innovation:2
- People Management:3
- Use of Corporate Assets:2
- Social Responsibility:4
- Quality of Management:2
- Financial Soundness:2
- Long-Term Investment Value:2
- Quality of Products/Services:6
- Global Competitiveness:3
- Sector:Health Care
- Culture rank:34
- Process rank:14
- Product rank:46
Johnson & Johnson stock chart
Latest news on Johnson & Johnson
Johnson & Johnson in Fortune Rankings
2024
2023
2024
2023
2024
2023
2024
2023
2024
2023
